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A 14-year-old boy presented with asymptomatic right hydronephrosis detected on routine yearly ultrasound examination.
Previously, he had at least two normal renal ultrasonograms, 4 years after remission of acute myeloblastic leukemia, treated by
AML-BFM-93 protocol. A function of the right kidney and no damage on the left was conﬁrmed by a DMSA scan. Right
retroperitoneoscopic nephrectomy revealed 3 renal arteries with the lower pole artery lying on the pelviureteric junction.
Histologically chronic tubulointerstitial nephritis was detected. In the pathogenesis of this severe unilateral renal damage, we
suspect the exacerbation of deleterious eﬀects of cytostatic therapy on kidneys with intermittent hydronephrosis.
1.Introduction
Renal damage as a consequence of hematologic malignancy
and cytostatic therapy is well known; however, we report
an unusual case of unilateral kidney lesion associated with
obstructive uropathy. Obstruction to urinary ﬂow can some-
t i m e sb ed i ﬃcult to diagnose. It was probably best deﬁned
as “any restriction to urinary outﬂow that left untreated
will cause progressive renal deterioration” [1]. Relation
between the degree and the duration of obstruction to the
amount of damage is still not evident, similarly as renal
capacity to recover after elimination of obstruction. Gen-
erally, symptoms can warn the clinicians about deleterious
eﬀects of obstruction. But asymptomatic damage is also
well known, subjecting patients with a dilatation of renal
collecting system to numerous exams. It remains unclear
whether cytostatic therapy or hematologic malignancy could
potentiate renal damage of hydronephrotic kidney.
2.CaseReport
A 14-year-old boy presented with right hydronephrosis. He
had no complaints, and this was an unexpected ﬁnding
detected by ultrasonography during his periodical health
test. The boy had a past history of acute myeloblastic
leukemia at 8 years of age. The disease was treated accord-
ing to AML-BFM-93 protocol, which includes cytarabine,
vepezide, daunorubicine, prednisolone, vincristine, adri-
omycin, cyclophosphamide, and tioguanine. A complete
remission was achieved 4 years ago. No signs of renal lesion
were recorded during and after chemotherapy. Previous
yearly ultrasound examinations showed no alteration of the
kidneys also. Having detected hydronephrosis, the patient
was admitted for further examination and treatment to the
Department of Urology.
Ultrasonography showed hydronephrosis on the right
with anteroposterior diameter of pelvis reaching 50mm,
calycealdilatation andparenchymal thinning. Ureter wasnot
dilated.Theleftkidneyseemednormal.Calculusobstructing
the pyeloureteral segment was suspected on the ﬁrst ultra-
sound test. However, no sign of urinary stone was detected
onDopplerultrasound,conﬁrmingaccessoryvesselextrinsic
to pyeloureteral junction.
His general blood test and urinalysis were normal,
and the serum concentration of creatinine was 59μmol/L.
Intravenous urography revealed normal left kidney, and no2 Case Reports in Medicine
excretion of the contrast material was seen on the right
side even on the late urograms. 99Tc-dimercaptosuccinic
acid (DMSA) scan was made to assess diﬀerential renal
function. It showed no renal uptake of DMSA on the right.
No anatomical or functional lesion was found in the left
kidney.
Nephrostomy was proposed as initial management with
a little hope for some part of renal function to recover.
The boy and his parents refused, willing for a deﬁnite
procedure. The right retroperitoneoscopic nephrectomy was
performed. Three renal arteries were found with the lower
pole artery lying on pyeloureteral junction. The kidney was
10.5 × 5.5cm of size, with slight atrophy of the parenchyma
(Figure 1). There were no intraoperative or postoperative
complications. Histopathology revealed chronic tubulointer-
stitial nephritis. Glomeruli showed no signiﬁcant changes.
A rather copious inﬁltration of lymphocytes, several plas-
mocytes, and granulocytes were present in stroma. An
obstruction of tubules with a prominent amount of small
eosinophilic and periodic acid-Schiﬀ (PAS) positive cylin-
ders was found. Tubular epithelium was focally detached.
There was a peritubular ﬁbrosis around excretory tubules
(Figure 2). Special attention was focused on the search of BK
nephritis, but no speciﬁc histological signs were found.
3. Discussion
The case is intriguing because of unusual combination.
Unilateral damage is diﬃcult to explain by the toxic eﬀects of
chemotherapy. No function on DMSA scan and intravenous
urography do not correlate with macroscopic ﬁndings of
removed kidney and no previous history of hydronephrosis.
Histological investigation also did not provide a straight-
forward answer. There was no widespread glomerular
collapse and tubular atrophy characteristic for chronically
obstructed kidney. Chronic tubulointerstitial nephritis can
be a consequence of vasculitis but no features of active or
healed vasculitis were detected. Peritubular ﬁbrosis around
excretory tubules might be due to leukemic cell inﬁltration,
which was one of the reasons of nephrectomy decision.
No histological conﬁrmation of this hypothesis was found,
even considering the 4-year period of remission of this
child’s leukemia. Leukemia can adversely aﬀect kidneys
in several ways. Common causes of leukemia-associated
decreased kidney function include direct parenchymal inﬁl-
tration by leukemic cells, tumor lysis syndrome, throm-
botic microangiopathy, radiation injury, and chemotherapy-
inducedtubularorvasculartoxicity.Othercausesthatshould
not be forgotten are some prerenal (i.e., volume depletion,
heart failure), postrenal (i.e., ureteral obstruction because of
lymphadenopathy), and infectious (BK virus) causes [2].
Acute renal side eﬀects of chemotherapy are well char-
acterized and some authors state that patients will sustain
renal injury due to the cytostatic therapy with nearly 95
per cent probability [3]. However, it must be taken into
consideration that not only cytostatics can play the principal
role in renal impairment. The majority of children treated
for hemoblastosis are exposed to wide spectrum of other
nephrotoxic drugs, in particular some antibiotics [3].
Figure 1: Macroscopic view of the kidney.
Figure 2: Histopathological view.
Clinical symptoms of renal injury may manifest as acute
renal failure or as diﬀerent symptoms of chronic renal
impairment. There is a paucity of data concerning late
nephrotoxicity that may interfere with the child’s develop-
ment and cause permanent morbidity [4]. Therefore, the
principal questions are to determine possible acute and
chronic nephropathy risks of anticancer therapy and to
standardize evaluation of kidney function in children after
the end of treatment.
If these parameters (urine microscopy and biochemistry,
serum concentrations of urea, creatinine and uric acid,) are
monitored in the course of the cytostatic therapy, the acute
impairment of the kidneys can be diagnosed early. Most
patients experience some spontaneous recovery from acute
nephrotoxicity after completing antineoplastic therapy. It is
recommended to monitor these patients thoroughly as they
represent a risk group for the development of possible irre-
versible changes of renal function [4]. A question, therefore,
appears of whether in the initial phases of cytostatic therapy
anotherbiochemicalparametersshouldbemonitored,which
would signalize milder changes in the glomerular and/or
tubular renal functions and what parameters must be moni-
tored to detect late nephrotoxic eﬀects.Case Reports in Medicine 3
Literary data state that patient should be followed up
after cessation of therapy with such tests: urinalysis, urinary
creatinine and calcium, β2-microglobulin, glomerular ﬁltra-
tion rate, tubular phosphorus reabsorption, and ultrasonog-
raphy [5].
The most frequent ﬁndings signalizing the renal impair-
ment are proteinuria and impairment of the concentration
ability of the kidneys [3]. In case of any abnormality, further
detailed tests should be performed and renal scan with
DMSA or 99Tc-mercaptoacetyltriglycine (MAG-3) seem to
be very predictive for renal damage [5]. In our case, the
pathogenesis and the role of hydronephrosis is not com-
pletely clear. The diagnosis of intermittent hydronephrosis
is suggested by the presence of an accessory vessel as an
extrinsic obstacle to urinary ﬂow and several normal renal
ultrasound examinations. Classically the main clinical symp-
tom of intermittent hydronephrosis is recurrent abdomi-
nal/ﬂank pain, usually accompanied by nausea and vomiting
[6, 7]. Other symptoms can be urinary infection, hematuria
[7]. Abdominal pain and nausea could have passed without
investigation during the course of chemotherapy because
of being attributed to the side eﬀects of chemotherapy. At
the terminal stage of renal damage with increased diuresis
of nonconcentrated urine, hydronephrosis became perma-
nent but did not cause symptoms. In case of intermittent
hydronephrosis,surgicalindicationsarediﬃculttostandard-
ize. Important hydronephrosis should be demonstrated on
imaging studies (ultrasonography, intravenous urography,
and diuretic renography) during an episode of pain [6, 7].
Between obstructive episodes, renal pelvic wall thickening
can be seen on ultrasonography [6]. Color Doppler ultra-
sonography helps to suspect an aberrant renal vessel. It
is reported that these children show a greater reduction
in diﬀerential renal function preoperatively, in contrast to
patients without crossing vessel, therefore, recommending
an early pyeloplasty [8]. General consensus is to perform
nephrectomy if the kidney comprises less than 10 percent of
diﬀerential function as assessed by a nuclear scan, probably
with exceptions in small children and bilateral renal damage.
Having only hypothesis of the development of renal damage
in our case, we recommend that children with dilatation
of renal collecting system and malignant disease should be
carefully evaluated and followed.
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